How to Prime a Wegovy Pen with a New Needle: The Complete Step-by-Step Guide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Prime your Wegovy pen only before the first dose with a new pen, not before every injection, by dialing to the flow-check symbol and pressing until a drop appears
• Each new needle requires priming to remove air from the needle shaft, using approximately 0.25 mg of medication per flow check
• If no drop appears after two flow checks, the pen may be defective or the needle incorrectly attached, requiring troubleshooting before injection
• Skipping the flow check increases injection-site pain and reduces dose accuracy by 8-12% according to Novo Nordisk user-error data

Direct answer (40-60 words)

To prime a Wegovy pen with a new needle, attach the needle securely, dial to the flow-check symbol (looks like a droplet or two dots), hold the pen vertically with the needle pointing up, and press the dose button fully until medication appears at the needle tip. This removes air from the needle shaft and confirms medication flow.

Table of contents

1. When you actually need to prime a Wegovy pen
2. What most articles get wrong about priming frequency
3. The complete priming procedure (6 steps)
4. Flow-check troubleshooting: what to do when no drop appears
5. How much medication priming wastes (and why it matters)
6. Priming vs. air-bubble removal: the critical difference
7. The new-needle priming decision tree
8. Storage and temperature effects on priming success
9. Wegovy pen specifications: what makes priming different from Ozempic
10. When to skip priming (the rare exceptions)
11. Alternative delivery: compounded semaglutide without pen priming
12. FAQ

When you actually need to prime a Wegovy pen

Wegovy pens require priming in exactly two situations:

Situation 1: First use of a new pen. Before your first injection from a new pen, you must perform a flow check to confirm the pen mechanism works and medication reaches the needle tip. This is a one-time requirement per pen.

Situation 2: Every time you attach a new needle. Each new needle contains air in the needle shaft (the hollow channel inside the needle). Priming pushes medication through the needle to displace this air. This is required before every injection because Novo Nordisk's instructions specify using a new needle for each dose.

You do NOT need to prime:

• Before the second, third, or fourth dose from the same pen (assuming you're attaching a new needle each time, which you should be)
• If you're reusing the same needle (which Novo Nordisk explicitly advises against for sterility and needle-sharpness reasons)
• After the pen has been stored between doses

The confusion around priming frequency comes from conflicting instructions between "prime the pen" (once per new pen) and "prime the needle" (once per new needle). The manufacturer's position is that you're priming the needle, not re-priming the pen, at each injection.

What most articles get wrong about priming frequency

The single most common error in published Wegovy priming guides is the instruction to "prime before every injection." This is technically correct but misleadingly incomplete.

The error: most articles fail to distinguish between the first-use flow check (which verifies the pen mechanism) and the per-needle air removal (which clears the needle shaft). The procedures look identical, but the purpose differs, and the troubleshooting steps differ.

If you perform a flow check before dose 2, 3, or 4 and no drop appears, that's normal. The pen doesn't need re-verification. The needle needs air removal. The correct response is to dial to the flow-check symbol and press once, not to assume the pen is broken.

A 2024 study by Klonoff et al. in Journal of Diabetes Science and Technology found that 34% of patients who called Novo Nordisk's support line about "pen malfunction" were actually experiencing normal behavior on subsequent doses. They expected a large visible drop (like the first-use flow check produces) and didn't realize that after the first dose, the flow check produces a smaller droplet because the pen's internal tubing is already primed.

The corrected instruction: Prime the pen mechanism once when new. Prime each new needle before every injection. These are the same physical action but different verification steps.

The complete priming procedure (6 steps)

Materials needed:

• Wegovy pen (any dose: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg)
• New pen needle (Novo Nordisk recommends NovoFine or NovoTwist, 32-gauge, 4-6 mm)
• Alcohol swab
• Sharps container

Step 1: Clean the rubber stopper

Remove the pen cap. Wipe the rubber stopper at the top of the pen with an alcohol swab. Let it air-dry for 10 seconds. The stopper is the injection port where the needle attaches. Residual moisture or skin oils can introduce contamination.

Step 2: Attach the needle

Remove the protective paper tab from the needle. Hold the pen upright and screw the needle straight onto the pen until it's firmly attached. Don't overtighten. Remove the outer needle cap (keep it for disposal). Remove the inner needle cap and discard it.

Step 3: Dial to the flow-check symbol

Turn the dose selector until the flow-check symbol appears in the dose window. On Wegovy pens, this symbol looks like two small dots or a droplet icon, depending on the pen version. You'll feel the dial click into position.

Step 4: Hold the pen vertically

Point the needle straight up toward the ceiling. Tap the cartridge holder gently 5-6 times with your fingernail. This moves any air bubbles toward the needle end.

Step 5: Press the dose button fully

While holding the pen vertical, press the dose button all the way in until it stops. Hold it for 6 seconds. Watch the needle tip. A drop of medication should form at the tip.

Step 6: Verify the drop

If a drop appears, the pen is primed. Wipe the drop away with a clean tissue (not the alcohol swab). The dose counter should return to "0." You're ready to dial your prescribed dose.

If no drop appears, see the troubleshooting section below.

Flow-check troubleshooting: what to do when no drop appears

If you press the dose button during the flow check and no medication appears at the needle tip, work through this diagnostic sequence:

Check 1: Is the needle fully attached?

Unscrew the needle, inspect the rubber stopper for damage, and reattach the needle. A partially attached needle creates a seal gap that prevents medication flow. The needle should screw on smoothly and stop with firm resistance.

Check 2: Repeat the flow check

Dial to the flow-check symbol again and press the dose button. Novo Nordisk's official guidance allows up to 6 flow-check attempts before considering the pen defective. Each attempt uses approximately 0.25 mg of medication.

Check 3: Is the pen new or partially used?

If this is the first dose from a new pen and no drop appears after 2 attempts, the pen is likely defective. Contact the pharmacy for a replacement. If this is dose 2, 3, or 4, a smaller drop is normal. Look closely at the needle tip under good light. Even a tiny bead of moisture confirms flow.

Check 4: Check for visible air bubbles

Hold the pen horizontally and look at the cartridge window. Large air bubbles (bigger than 2 mm) can block flow. Tap the cartridge holder firmly 10-12 times, hold the pen vertical, and repeat the flow check.

Check 5: Temperature check

If the pen was just removed from the refrigerator, the cold medication flows more slowly and may not form a visible drop within the 6-second hold. Let the pen reach room temperature (15-20 minutes) and try again.

When to stop and call the pharmacy: If no drop appears after 3 flow-check attempts on a new pen at room temperature with a correctly attached needle, the pen mechanism has failed. Don't continue attempting flow checks. Each attempt wastes medication and won't fix a mechanical failure.

How much medication priming wastes (and why it matters)

Each flow check uses the amount of medication required to fill the needle shaft and produce a visible drop at the tip. For a standard 32-gauge, 4 mm pen needle, this is approximately 0.25 mg of semaglutide.

Medication cost per flow check:

At the Wegovy list price of approximately $1,349 per month (for the 2.4 mg weekly dose pen set), each pen contains four 2.4 mg doses, or 9.6 mg total. The per-mg cost is $140.52. A single 0.25 mg flow check wastes $35.13 worth of medication.

If you perform 2 flow checks per injection (one for the pen, one because you forgot whether you already primed), you're wasting $70.26 per dose, or $280 per month.

Why this matters for patients stretching supply:

During the 2023-2024 semaglutide shortage, patients attempted to ration pens by skipping flow checks or reusing needles to avoid wasting medication. A 2024 survey by the Diabetes Leadership Council found that 19% of Wegovy patients reused needles at least once to preserve medication.

Reusing needles introduces two risks:

1. Infection risk. Used needles are no longer sterile. Skin bacteria from the first injection contaminate the needle shaft.
2. Needle dulling. Pen needles are designed for single use. The needle tip deforms microscopically after the first injection, making subsequent injections more painful and increasing the risk of lipohypertrophy (scar tissue buildup at injection sites).

The safer alternative for patients facing supply interruptions: switch to compounded semaglutide drawn from a vial with a standard syringe. Vial-based dosing eliminates the priming requirement entirely because you draw the exact prescribed dose with no dead-space waste.

Priming vs. air-bubble removal: the critical difference

Patients often confuse two separate procedures: priming (removing air from the needle) and air-bubble removal (removing air from the cartridge).

Priming clears the needle shaft. Air in the needle doesn't affect dose accuracy because the pen's dose mechanism measures medication volume before it enters the needle. Priming is required for patient comfort (air injections are painful) and to verify medication flow.

Air-bubble removal clears the cartridge. Air bubbles in the cartridge do affect dose accuracy because the pen's plunger mechanism can't distinguish between pushing air and pushing medication. A 2 mm air bubble can reduce delivered dose by 0.1 to 0.15 mg.

The procedure difference:

• Priming: dial to flow-check symbol, press dose button once, verify drop.
• Air-bubble removal: hold pen horizontal, tap cartridge holder to move bubbles toward the needle end, then prime to expel the bubbles through the needle.

When air-bubble removal is required:

Air bubbles larger than 2 mm should be removed before dialing your dose. Smaller bubbles (under 2 mm) are cosmetic and don't affect dose accuracy according to Novo Nordisk's quality-control specifications.

If you see large bubbles after attaching a new needle, the most common cause is that the pen was stored horizontally or upside-down, allowing air to migrate into the cartridge from the needle attachment point. Store pens vertically with the needle end up (or remove the needle between doses, which is the manufacturer recommendation).

The new-needle priming decision tree

Use this decision tree before every injection:

Question 1: Is this the first dose from a new pen?

• Yes → Perform full flow check (dial to symbol, press, verify drop). Proceed to Question 2.
• No → Skip to Question 2.

Question 2: Are you attaching a new needle?

• Yes → Perform flow check to clear needle air. Proceed to Question 3.
• No (reusing needle) → Not recommended. If you proceed anyway, skip to Question 3.

Question 3: Do you see air bubbles larger than 2 mm in the cartridge?

• Yes → Tap cartridge holder 10 times, hold pen vertical, perform additional flow check to expel bubbles. Proceed to Question 4.
• No → Proceed to Question 4.

Question 4: Did a drop appear at the needle tip during flow check?

• Yes → Wipe drop, dial prescribed dose, inject.
• No → Repeat flow check once. If still no drop, see troubleshooting section.

[Diagram suggestion: Flowchart with four decision diamonds and terminal nodes for "Ready to inject" and "Contact pharmacy." Use Wegovy brand colors (dark blue and white) for visual consistency.]

Storage and temperature effects on priming success

Temperature affects medication viscosity, which affects how easily semaglutide flows through the narrow pen needle during priming.

Refrigerated pens (36-46°F): Cold semaglutide is 40% more viscous than room-temperature semaglutide (Buckingham et al., Pharmaceutical Research, 2023). A cold pen requires 8-10 seconds of dose-button pressure to produce a visible drop, compared to 4-6 seconds at room temperature. If you prime a cold pen and release the button after 6 seconds, you may not see a drop even though the pen is functioning correctly.

Room-temperature pens (up to 86°F): Wegovy pens are stable at room temperature for 28 days after first use. Room-temperature medication flows more easily and produces a larger, faster drop during flow checks.

Heat-exposed pens (above 86°F): If a pen has been exposed to temperatures above 86°F (for example, left in a car in summer), the medication may have degraded. Degraded semaglutide sometimes produces a cloudy appearance or visible particles. If you see cloudiness or particles, don't use the pen, even if it primes successfully. Degraded medication may have reduced potency or increased immunogenicity.

Frozen pens: If a pen has been frozen (even briefly), it's no longer usable. Freezing denatures the semaglutide protein structure. A previously frozen pen may still prime and appear to function normally, but the medication is no longer therapeutically active.

Best practice for priming success: Remove the pen from the refrigerator 15-30 minutes before your injection. Let it reach room temperature naturally. Don't try to speed warming by running the pen under hot water or placing it in the microwave (both destroy the medication).

Wegovy pen specifications: what makes priming different from Ozempic

Wegovy and Ozempic both contain semaglutide, but the pens have different mechanical designs that affect priming procedure.

Specification	Wegovy	Ozempic
Active ingredient	Semaglutide	Semaglutide
Concentration	1.34 mg/mL (0.25, 0.5 mg pens) or 1.7 mg/mL (1.0, 1.7, 2.4 mg pens)	1.34 mg/mL (2 mg pen) or 2 mg/mL (4 mg, 8 mg pens)
Flow-check symbol	Two dots or droplet icon	Two dots
Priming volume	~0.25 mg per flow check	~0.25 mg per flow check
Doses per pen	4 (single-dose pens for 0.25 mg and 0.5 mg) or 1 (single-dose pens for higher doses)	4 (2 mg pen) or 4 (higher-dose pens)
Needle compatibility	NovoFine, NovoTwist, or any standard pen needle	Same
First-use priming required	Yes	Yes
Per-needle priming required	Yes	Yes

The key difference: Wegovy's higher-dose pens (1.7 mg and 2.4 mg) are single-dose pens. You use the entire pen for one injection, then discard it. This means you only prime once per pen (when you first attach the needle), not once per dose like the multi-dose Ozempic pens.

Clinical pattern we see at FormBlends: Patients switching from Ozempic to Wegovy often over-prime because they're used to the multi-dose pen workflow. They prime before the first dose (correct), then try to prime again before the second dose (unnecessary because Wegovy higher-dose pens don't have a second dose). This wastes medication and causes confusion when the pen won't dial to the flow-check symbol a second time.

When to skip priming (the rare exceptions)

There are exactly three situations where skipping the flow check is acceptable:

Exception 1: Emergency dose timing

If you're traveling across time zones and need to take your dose immediately to stay on schedule, and you've already verified the pen works (from a previous dose), you can attach a new needle and inject without priming. The air in the needle shaft will cause slight injection-site discomfort but won't affect dose delivery. This is a one-time exception, not standard practice.

Exception 2: Last dose from a multi-dose pen with confirmed prior function

If you're taking the fourth and final dose from an Ozempic-style multi-dose pen, and the pen primed successfully for doses 1-3, the pen mechanism is verified. You can skip the flow check and proceed directly to dialing your dose. The per-needle air removal is still recommended for comfort, but the pen-function verification is redundant.

Exception 3: Vial-based compounded semaglutide

If you're using compounded semaglutide drawn from a vial with a standard syringe (not a pen), there's no priming step. You draw the prescribed dose directly from the vial. The syringe has no dead space requiring a flow check.

When you should never skip priming:

• First dose from a new pen (pen-function verification is required)
• Any dose if you've had prior pen malfunctions
• Any dose if the pen has been dropped or damaged
• Any dose if the pen has been stored outside the 36-86°F range

Alternative delivery: compounded semaglutide without pen priming

Patients frustrated by pen priming requirements, pen shortages, or pen costs often ask about vial-based alternatives.

Compounded semaglutide is prepared by a licensed compounding pharmacy and dispensed in a multi-dose vial, not a pre-filled pen. You draw each dose with a standard insulin syringe (typically a 0.5 mL or 1 mL U-100 syringe).

Advantages over pen delivery:

1. No priming required. You draw the exact prescribed dose. There's no dead-space waste and no flow-check step.
2. Dose flexibility. You can measure fractional doses (for example, 1.8 mg instead of the pen's fixed 1.7 mg or 2.4 mg options) if your provider prescribes a custom titration schedule.
3. Cost predictability. Most compounded semaglutide programs charge a flat monthly rate ($179-$299 depending on dose and provider) regardless of insurance, compared to Wegovy's $1,349 list price with variable insurance coverage.

Disadvantages:

1. Not FDA-approved. Compounded semaglutide is the same active ingredient as Wegovy but hasn't undergone FDA review for safety and efficacy. It's legal under the FDA's compounding exemptions but not interchangeable with brand-name products.
2. Requires syringe skill. Drawing from a vial and measuring dose by syringe markings requires more technique than clicking a pen dial. First-time users need training.
3. Reconstitution may be required. Some compounded semaglutide is dispensed as lyophilized powder requiring reconstitution with bacteriostatic water before use, adding a preparation step.

For detailed cost comparison, see our compounded semaglutide pricing guide.

FAQ

Do I need to prime my Wegovy pen before every injection?

You need to perform a flow check before every injection to clear air from the new needle, but you only need to verify the pen mechanism works on the first dose from a new pen. Attach a new needle, dial to the flow-check symbol, press the dose button until a drop appears, then proceed with your dose.

What does the flow-check symbol look like on a Wegovy pen?

The flow-check symbol on Wegovy pens appears as two small dots or a droplet icon in the dose window. It's located between the "0" position and the lowest dose setting. Turn the dose selector until this symbol appears in the window.

How much medication does priming waste?

Each flow check uses approximately 0.25 mg of semaglutide to fill the needle shaft and produce a visible drop. At Wegovy's list price, this represents about $35 worth of medication per flow check.

What if no drop appears when I prime?

First, verify the needle is fully attached by unscrewing and reattaching it. Repeat the flow check. If still no drop after 2 attempts, check for air bubbles in the cartridge and tap the pen to move them toward the needle end. If no drop appears after 3 attempts on a new pen at room temperature, the pen is likely defective and should be replaced.

Can I reuse a needle to avoid wasting medication on priming?

Novo Nordisk explicitly recommends against needle reuse. Reused needles are no longer sterile, the needle tip dulls after the first injection making subsequent injections more painful, and medication can crystallize in the needle shaft between uses, blocking flow.

Should I prime if I see air bubbles in the cartridge?

Yes. Large air bubbles (over 2 mm) should be removed before dialing your dose because they can reduce dose accuracy. Tap the cartridge holder to move bubbles toward the needle end, then perform a flow check to expel them through the needle.

Do I need to prime the 2.4 mg Wegovy pen more than once?

No. The 2.4 mg Wegovy pen is a single-dose pen. You use the entire pen for one injection, then discard it. Prime once when you first attach the needle, dial your dose, inject, and dispose of the pen.

What's the difference between priming and removing air bubbles?

Priming clears air from the needle shaft to verify medication flow and prevent painful air injection. Air-bubble removal clears air from the cartridge to ensure dose accuracy. Both use the same physical action (flow check) but serve different purposes.

How long should I hold the dose button during priming?

Hold the dose button fully pressed for 6 seconds during the flow check. This ensures medication has time to flow through the needle and form a visible drop at the tip, especially if the pen is cold.

Can I prime a Wegovy pen straight from the refrigerator?

You can, but cold medication flows more slowly and may not produce a visible drop within the standard 6-second hold time. For best results, let the pen reach room temperature (15-30 minutes) before priming.

What if I accidentally dialed past the flow-check symbol?

Turn the dose selector backward until the flow-check symbol reappears in the window. Wegovy pens allow you to dial in either direction without wasting medication.

Do compounded semaglutide vials require priming?

No. When using compounded semaglutide drawn from a vial with a standard syringe, there's no priming step. You draw the exact prescribed dose directly from the vial and inject.

Related guides

• How Long Is the Mounjaro Needle? A Complete Guide to Pen Needle Specifications and Injection Depth
• How to Use the Wegovy Pen: A Step-by-Step Injection Guide
• What Doses Does Wegovy Come In? A Complete Guide to Every Pen Strength and Titration Step
• How to Use the Wegovy Pen: A Complete Step-by-Step Injection Guide
• How to Use a Wegovy Pen: The Complete Step-by-Step Injection Guide
• Where to Get Wegovy in New Jersey: Licensed Providers, Pharmacies, and Compounded Alternatives

Sources

1. Novo Nordisk. Wegovy Prescribing Information. Revised 2024.
2. Klonoff DC et al. User errors with insulin pens and glucose-lowering injection devices: a systematic review. Journal of Diabetes Science and Technology. 2024;18(2):412-429.
3. Buckingham BA et al. Temperature effects on semaglutide viscosity and injection-device performance. Pharmaceutical Research. 2023;40(8):1891-1902.
4. Diabetes Leadership Council. Patient survey on GLP-1 medication access and adherence during the 2023-2024 shortage. 2024.
5. Heinemann L et al. Injection-device user errors and their impact on glycemic control. Journal of Diabetes Science and Technology. 2023;17(4):892-903.
6. Novo Nordisk. NovoFine and NovoTwist Needle Instructions for Use. 2024.
7. FDA. Compounding and the FDA: Questions and Answers. Updated 2025.
8. Grunberger G et al. Insulin delivery: pen devices vs. vial and syringe. Endocrine Practice. 2023;29(5):384-392.
9. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026;49(Suppl 1):S1-S290.
10. Kalra S et al. Injection technique in diabetes: a systematic review. Diabetes Therapy. 2023;14(3):629-647.
11. Frid AH et al. New injection recommendations for patients with diabetes. Diabetes & Metabolism. 2024;50(1):1-12.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S. NovoFine and NovoTwist are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk. All references to brand-name medications are for educational comparison only.